Bioskryb
2 known investors
BioSkryb Genomics develops single-cell multiomics technology, including its patented primary template-directed amplification (PTA) method and ResolveDNA, ResolveOME kits and BaseJumper bioinformatics platform, to analyze the genome, transcriptome, and surface proteins of individual cells. Its products serve research, biopharma, diagnostics, and AI-driven precision medicine partners working in oncology, neurology, and clinical development.
AI & Machine LearningBiotechDigital Health